JP Patent

JP3672342B2 — ビスホスホン酸又はその誘導体を含有する注射液とその安定化方法、及び注射液アンプル

Assigned to Astellas Pharma Inc · Expires 2005-07-20 · 21y expired

What this patent protects

Patent listed against fosnetupitant-chloride-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP3672342B2
Jurisdiction
JP
Classification
Expires
2005-07-20
Drug substance claim
No
Drug product claim
No
Assignee
Astellas Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.